Reducing visceral adipose tissue mass is essential for improving endothelial function in type 2 diabetes prone individuals

被引:28
|
作者
Rittig, K. [1 ]
Hieronimus, A. [1 ]
Thamer, C. [1 ]
Machann, J. [2 ]
Peter, A. [1 ]
Stock, J. [1 ]
Schick, F. [2 ]
Fritsche, A. [1 ]
Stefan, N. [1 ]
Haering, H. -U. [1 ]
Balletshofer, B. [1 ]
机构
[1] Univ Tubingen, Dept Endocrinol & Diabet, D-72076 Tubingen, Germany
[2] Univ Tubingen, Dept Radiol, Sect Expt Radiol, D-72076 Tubingen, Germany
关键词
Visceral adiposity; Endothelial dysfunction; Lifestyle intervention; WEIGHT-LOSS; INSULIN-RESISTANCE; METABOLIC SYNDROME; MYOCARDIAL-INFARCTION; PHYSICAL-ACTIVITY; MEDIA THICKNESS; CAROTID-ARTERY; OBESE SUBJECTS; FATTY LIVER; DYSFUNCTION;
D O I
10.1016/j.atherosclerosis.2010.06.042
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: In obesity, particularly increased visceral-(VAT), but not total (TAT) adipose tissue mass is a major source of proinflammatory cytokine expression and secretion. VAT, more than TAT, is associated with endothelial dysfunction (ED), which is an accepted risk factor for atherosclerosis. Consequently, we hypothesized that during a lifestyle intervention specifically a decrease in VAT, rather than TAT, is associated with improved ED and vascular adhesion molecules in type 2 diabetes prone subjects. Methods: Analyses were done in 189 individuals (age: 45.4 +/- 0.8 years) at increased risk of type 2 diabetes, who underwent a 9-month lifestyle intervention. ED expressed as flow mediated dilation (FMD) of the brachial artery, sE-selectin, sV-CAM, sI-CAM, TAT and VAT (measured by magnetic resonance tomography) was determined. Results: There was a mean decrease in body weight (-3%, p < 0.0001), TAT (-7.6%, p < 0.0001) and VAT (-12.5%, p < 0.0001), while FMD increased (+ 9.1%, p = 0.04). The change in FMD was not associated with change in body weight (p = 0.35) or TAT (p = 0.21) but with a decrease in VAT (r = -0.19, p = 0.009). In a post hoc analysis, the subjects were divided by the median change in VAT into responders and non-responders. FMD increased only in the responders (from 6.2 +/- 0.4% to 8.0 +/- 0.5%, p = 0.0005) but not in the non-responders (p = 0.15). Also sE-selectin significantly decreased only in the responders (from 54 +/- 4 ng/ml to 47 +/- 3 ng/ml; p = 0.03). Conclusion: During a lifestyle intervention, not weight loss or decrease in TAT, but decrease in VAT is associated with improved ED in individuals prone to type 2 diabetes. Therefore, primary cardiovascular prevention should focus specifically on reducing VAT rather than body weight alone. (C) 2010 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:575 / 579
页数:5
相关论文
共 50 条
  • [1] Excess Visceral Adipose Tissue Worsens the Vascular Endothelial Function in Patients with Type 2 Diabetes Mellitus
    Kurozumi, Akira
    Okada, Yosuke
    Arao, Tadashi
    Tanaka, Yoshiya
    INTERNAL MEDICINE, 2016, 55 (21) : 3091 - 3095
  • [2] Visceral Adipose Tissue: The Hidden Culprit for Type 2 Diabetes
    Dhokte, Sneha
    Czaja, Krzysztof
    NUTRIENTS, 2024, 16 (07)
  • [3] Rosiglitazone selectively increases subcutaneous but not visceral adipose tissue mass in type 2 diabetes mellitus
    Banerji, M
    Lebovitz, H
    Dugbartey, M
    DIABETES, 2001, 50 : A90 - A90
  • [4] Association of visceral adipose tissue with echocardiographic abnormalities in type 2 diabetes patients
    Martinez-Dominguez, P.
    Guerra, E. C.
    Gomez-Aviles, P.
    Antonio-Villa, N. E.
    Almeda-Valdes, P.
    Espinola-Zavaleta, N.
    Ana-Bayona, M. J. Santa
    Rosado, A. Martagon
    Campos-Munoz, A.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [5] Visceral and Subcutaneous Adipose Tissue Attenuation Differs by Type 1 and Type 2 Diabetes Status
    Keshawarz, Amena
    Alman, Amy C.
    Wang, Cecilia C. Low
    Mitchell, Stacey
    Schauer, Irene E.
    Reusch, Jane E. B.
    Regensteiner, Judith G.
    Snell-Bergeon, Janet K.
    DIABETES, 2019, 68
  • [6] Relation of abdominal visceral and subcutaneous adipose tissue to markers of inflammation in type 2 diabetes
    Mazzone, T.
    Haffner, S.
    Davidson, M. H.
    D'Agostino, R. B.
    Feinstein, S.
    Kondos, G.
    Perez, A.
    Sam, S.
    DIABETOLOGIA, 2008, 51 : S337 - S337
  • [7] Subcutaneous and Visceral Adipose Tissue Gene Expression of Serum Adipokines That Predict Type 2 Diabetes
    Samaras, Katherine
    Botelho, Natalia K.
    Chisholm, Donald J.
    Lord, Reginald V.
    OBESITY, 2010, 18 (05) : 884 - 889
  • [9] VISCERAL ADIPOSE TISSUE IS RELATED WITH CORONARY ARTERY CALCIUM SCORE IN SUBJECTS WITH TYPE 2 DIABETES
    Breder, I.
    Wolf, V. L. W.
    Luchiari, B. M.
    Dos Santos, M. S. L.
    Barreto, J.
    Pascoa, M. A.
    Coelho Filho, O. R.
    De Souza, T. F.
    Guerra-Junior, G.
    Sposito, A.
    ATHEROSCLEROSIS, 2020, 315 : E127 - E127
  • [10] Proteomic analysis of visceral adipose tissue in pre-obese patients with type 2 diabetes
    Murri, Mora
    Insenser, Maria
    Rosa Bernal-Lopez, Maria
    Perez-Martinez, Pablo
    Escobar-Morreale, Hector F.
    Tinahones, Francisco J.
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2013, 376 (1-2) : 99 - 106